
Citwell, accelerators of transformation

The main chapters of this page:
The challenges of the sector
Your problems and our solutions
Segmentation of Markets/Customers/Products
- Set up differentiated service and flexibility policies (Service Level Agreement with the markets)
- Streamline the product portfolio by market typology (mature/emerging)
- Adapt the distribution strategy by market (direct distribution, partners, storage points, etc.)
Mastery of demand
- Plan collaborative sales with markets and/or distributor partners
- Integrate calls for tenders into statistical forecasts on mature products
- Adapt a differentiated management of forecasts for promotions, launch/end of life, « switch » products
- Set up VMI (Vendor Managed Inventory) between factories and markets, with some third-party customers and distributors
Industrial agility and logistics
- Improve the responsiveness and flexibility of industrial resources (reduction of cycles, reduction of firm horizons, optimization of batch sizes, etc.)
- Adapt the management of flows and stocks (pull / pushed flows, point of decoupling at the level of active and semi-finished principles, delayed differentiation to packaging, etc.)
- Adapt stock policies to desired service levels and responsiveness of industrial and logistics tools
« End-to-end » Optimization
- Master the long, medium and short-term balance between demand and capacity, combining a strategic vision (commercial locations), economic (budgets, margins) and customer service (service rate)
- Synchronize sites and markets around the S&OP loop (market-oriented S&OP, production and distribution master plans, etc.)
- Reduce total costs (purchase, trade, production, logistics, etc.)
The concerned expertise



My title
My Subtitle
Guillaume Allemand
Pharmaceutical & Chemistry Expert
Managing partner of the firm, Guillaume particularly intervenes in the sectors of Life Science, Pharmaceutics and Chemistry. Throughout his career, he led many transformation projects and accompanied change for large groups and smaller companies, from diagnosis to operational implementation. Guillaume recently worked with various actors of the sector such as Aguettant, BayerCropsciences, BioMerieux, Expanscience, Galderma, MSD (Merck Sharp & Dohme), Novacyl, Sanofi, Solvay or 3iNature.